Trending: Eli Lilly Buys DICE Therapeutics in Deal Worth $2.4 Billion
20 Juin 2023 - 4:15PM
Dow Jones News
09:45 ET -- Eli Lilly is one of the most mentioned companies in
the U.S. across all news items in the last 12 hours, according to
Factiva data. Eli Lilly said Tuesday it is paying $48 a share of
DICE Therapeutics to buy the smaller biopharmaceutical company for
$2.4 billion, which would represent a premium of about 40% to
DICE's 30-day volume-weighted average trading price up to its last
trading day on Friday. The transaction is expected to close in the
third quarter of this year. Dow Jones & Co. owns Factiva.
(chris.wack@wsj.com)
(END) Dow Jones Newswires
June 20, 2023 10:00 ET (14:00 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
DICE Therapeutics (NASDAQ:DICE)
Graphique Historique de l'Action
De Avr 2024 à Mai 2024
DICE Therapeutics (NASDAQ:DICE)
Graphique Historique de l'Action
De Mai 2023 à Mai 2024
